| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 1 |
| 1 | ASPIRIN 325 MG | 1 |
| 2 | ASPIRIN 81 MG | 1 |
| 3 | BARICITINIB | 1 |
| 4 | IDELALISIB | 1 |
| 5 | NIVOLUMAB | 1 |
| 6 | OCTREOTIDE ACETATE | 1 |
| 7 | RITUXIMAB | 1 |
| 8 | SPESOLIMAB | 1 |
| 9 | SPESOLIMAB-SBZO | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPESOLIMAB | 1 | 0.0025 |
| 1 | BARICITINIB | 1 | 0.0003 |
| 2 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 1 | 0.0000 |
| 3 | OCTREOTIDE ACETATE | 1 | 0.0000 |
| 4 | TRIAMCINOLONE ACETONIDE | 1 | 0.0000 |
| 5 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 1 | 0.0000 |
| 6 | NIVOLUMAB | 1 | 0.0000 |
| 7 | RITUXIMAB | 1 | 0.0000 |
| 8 | ASPIRIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 1 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |